3,820 Shares in Marsh & McLennan Companies, Inc. $MRSH Acquired by Sumitomo Life Insurance Co.

Sumitomo Life Insurance Co. purchased a new stake in Marsh & McLennan Companies, Inc. (NYSE:MRSH) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 3,820 shares of the financial services provider’s stock, valued at approximately $637,000.

Several other large investors also recently modified their holdings of MRSH. Landscape Capital Management L.L.C. acquired a new stake in shares of Marsh & McLennan Companies during the 2nd quarter worth approximately $1,571,000. Korea Investment CORP acquired a new position in shares of Marsh & McLennan Companies during the 2nd quarter valued at $46,856,000. EP Wealth Advisors LLC bought a new position in Marsh & McLennan Companies during the second quarter worth $6,762,000. Ieq Capital LLC acquired a new stake in Marsh & McLennan Companies in the second quarter worth $13,905,000. Finally, Callan Family Office LLC bought a new stake in Marsh & McLennan Companies in the second quarter valued at $11,100,000. Institutional investors and hedge funds own 87.99% of the company’s stock.

Insider Buying and Selling

In other Marsh & McLennan Companies news, Director Lloyd M. Yates sold 12,000 shares of the firm’s stock in a transaction on Thursday, July 23rd. The stock was sold at an average price of $175.65, for a total transaction of $2,107,800.00. Following the transaction, the director directly owned 12,001 shares in the company, valued at approximately $2,107,975.65. This trade represents a 50.00% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Paul Beswick sold 713 shares of the company’s stock in a transaction on Wednesday, July 29th. The stock was sold at an average price of $198.00, for a total transaction of $141,174.00. Following the completion of the sale, the senior vice president owned 16,376 shares of the company’s stock, valued at approximately $3,242,448. The trade was a 4.17% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 36,469 shares of company stock valued at $6,291,345 in the last 90 days. Insiders own 0.38% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on MRSH shares. Wells Fargo & Company increased their price objective on shares of Marsh & McLennan Companies from $186.00 to $188.00 and gave the stock an “equal weight” rating in a research report on Wednesday, July 22nd. Mizuho upped their price target on Marsh & McLennan Companies from $197.00 to $201.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 22nd. Piper Sandler cut their price target on Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating on the stock in a report on Tuesday, May 26th. Cantor Fitzgerald boosted their price objective on Marsh & McLennan Companies from $210.00 to $218.00 and gave the company an “overweight” rating in a report on Thursday, July 9th. Finally, JPMorgan Chase & Co. upped their target price on Marsh & McLennan Companies from $206.00 to $212.00 and gave the stock an “overweight” rating in a research report on Monday, July 13th. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, eleven have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $203.50.

Marsh & McLennan Companies Price Performance

NYSE:MRSH opened at $192.17 on Friday. The company has a current ratio of 1.14, a quick ratio of 1.14 and a debt-to-equity ratio of 1.22. Marsh & McLennan Companies, Inc. has a one year low of $156.60 and a one year high of $212.65. The company has a market capitalization of $91.71 billion, a P/E ratio of 23.49, a PEG ratio of 2.75 and a beta of 0.59. The stock’s 50-day simple moving average is $179.88.

Marsh & McLennan Companies (NYSE:MRSH) last issued its quarterly earnings data on Tuesday, July 21st. The financial services provider reported $2.96 EPS for the quarter, topping the consensus estimate of $2.89 by $0.07. Marsh & McLennan Companies had a return on equity of 32.67% and a net margin of 14.24%.The firm had revenue of $7.28 billion during the quarter. Marsh & McLennan Companies’s revenue was up 6.2% compared to the same quarter last year. On average, equities research analysts expect that Marsh & McLennan Companies, Inc. will post 10.43 earnings per share for the current fiscal year.

Marsh & McLennan Companies Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, August 14th. Investors of record on Thursday, July 23rd were given a $0.99 dividend. This represents a $3.96 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date of this dividend was Thursday, July 23rd. This is an increase from Marsh & McLennan Companies’s previous quarterly dividend of $0.90. Marsh & McLennan Companies’s payout ratio is currently 48.41%.

About Marsh & McLennan Companies

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.